Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with hallucinations
ICD-10 F19.951 is a billable code used to indicate a diagnosis of other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with hallucinations.
F19.951 refers to a condition characterized by the use of unspecified psychoactive substances that leads to a psychotic disorder, specifically manifesting as hallucinations. This diagnosis is often seen in individuals who engage in the use of various substances, including but not limited to synthetic drugs, hallucinogens, or other non-specified psychoactive agents. The psychotic disorder is marked by significant alterations in perception, thought processes, and emotional responses, which can severely impact daily functioning. Patients may experience visual or auditory hallucinations, delusions, and disorganized thinking. The onset of these symptoms typically correlates with substance use, and the severity can vary based on the type and amount of substance consumed. Treatment often involves a combination of detoxification, psychiatric intervention, and rehabilitation programs aimed at addressing both the substance use disorder and the associated psychotic symptoms. Understanding the nuances of this diagnosis is crucial for effective treatment and management.
Detailed psychiatric evaluation, including substance use history and mental status examination.
Patients presenting with acute psychosis following substance use, requiring hospitalization.
Documentation must clearly differentiate between substance-induced symptoms and underlying psychiatric conditions.
Comprehensive assessment of substance use patterns, withdrawal symptoms, and treatment history.
Patients undergoing detoxification who exhibit psychotic symptoms.
Focus on the interplay between substance use and mental health, requiring thorough documentation of both aspects.
Used when managing a patient with substance-induced psychosis in an outpatient setting.
Document the patient's history, mental status examination, and treatment plan.
Psychiatrists should ensure comprehensive assessments are documented.
F19.951 includes the presence of psychotic symptoms, specifically hallucinations, while F19.920 refers to other psychoactive substance use without psychotic features.
